RetiSpec secures $13.8 million Series A to detect Alzheimer’s early through retinal imaging
American pharmaceutical giant Eli Lilly and medical device provider Topcon Healthcare join as strategic investors.
American pharmaceutical giant Eli Lilly and medical device provider Topcon Healthcare join as strategic investors.
Biovectra is being purchased for the second time in five years.
The San Diego-based startup is looking to secure FDA and Health Canada clearance for its blood-testing platform.
Startup aims to speed up the technology procurement process for healthcare providers.
Changes in top leadership also hit Faire, Kovo HealthTech, goeasy, CFI, and more.
Partners in the $44-million project include ORX, Well Health, Healwell AI, Tali AI, and Simon Fraser University.
The clinical facility aims to be the first dedicated to producing bioprinted tissue therapeutics in Canada.
Neuroscientist and former Google Pixel PM team up to tackle workplace stress with Roga.
LifeLabs will retain its brand, Canadian headquarters, and management after the acquisition is closed.
Healwell CEO touts access to xAI’s closed developer program as big potential benefit.
Private contributions bring the collective project values up to $32 million.
FedDev invested nearly $20 million across nine Ottawa-based companies.
VoxCell’s 3D bioprinted imitation of natural soft tissue helps pharmaceutical companies test new drugs faster.
Plus: Telehealth execs charged with fraud.
The deals, if successful, will have a combined value of over $36 million.